GLP1 receptor agonists improve glycemic control, promote weight loss, and reduce hepatic fat content effects that align with MASH treatment goals
To accurately measure the amount of visceral fat, you can use InBody devices, DEXA scans, or MRI
A PubMed study demonstrated that oral Anavar decreased subcutaneous abdominal fat more than testosterone injections or weight loss alone, and also showed favorable changes in visceral fat
These include bone and muscle loss, cardiovascular deconditioning, delayed wound healing and bone fracture healing, and impaired immune function ( It is quasi-impossible, on Earth, to study effects in the absence of gravity, also referred to as weightlessness
This makes tirzepatide a potent option for those seeking to manage their weight, especially for individuals who may not have had success with other treatments